Skip to content
Tirzepatide Report
Provider review

Joi + Blokes Tirzepatide Review: Quarterly Price & Terms

Published by Tirzepatide ReportUpdated

FDA warning letter
FDA issued Joi and Blokes dba Joi + Blokes a warning letter in June 2026 (False & Misleading Claims/Misbranded (Telehealth)). Read the letter on FDA’s own warning-letter database.

On this page

Compounded tirzepatide with coaching, $149 first month then $249/month billed quarterly.

Standout details

  • Named tirzepatide price distinguishes introductory and ongoing rates
  • Clinician access and health coaching included

Things to consider

  • Quarterly billing and general minimum commitment
  • Cancellation wording differs across public pages

Joi + Blokes currently lists compounded tirzepatide at $249 per month after a $149 first-month offer, billed quarterly. The same page separately lists semaglutide at $179 after a $99 first month. The lower semaglutide figures do not price tirzepatide, and quarterly billing is not a flexible month-to-month payment arrangement.3

The named tirzepatide card includes medication, dosing support, clinician consultations and health coaching. Its page says there is no separate membership fee and labs are optional. Confirm the actual amount due for the selected quarter and the renewal charge; the introductory monthly label alone does not establish the first checkout total.3

What the platform provides

The Joi and Blokes brands organize services for women and men within a broader hormone and wellness platform. The reviewed GLP-1 page describes health-coach visits, clinician access, nutrition support, messaging and delivery. Those services do not establish that a coach is a Registered Dietitian or that hormone treatment is included in a tirzepatide subscription.3

Its public process begins with health history and discussion with a clinician; an independent provider determines whether a prescription is appropriate. The footer expressly says Joi + Blokes does not provide medical care or manufacture the medication. Completing an assessment does not itself create a clinician-patient relationship with the platform or guarantee eligibility.3,4

Named tirzepatide plan

ItemPublished terms
Introductory label$149 first month
Ongoing label$249/month, billed quarterly
Included servicesMedication, clinician consultations and coaching
LabsOptional; purchases separate and nonrefundable
Named tirzepatide plan

Read quarterly pricing with the cancellation terms

The page advertises easy cancellation and says a plan can be adjusted or canceled anytime. Its Terms, last updated September 15, 2025, describe subscriptions with a minimum three consecutive months and a request 30 days before the next monthly processing date after the initial commitment. These statements are not fully reconciled with the quarterly offer. Obtain the applicable commitment, processing date and cancellation deadline for the selected plan instead of assuming the easiest wording governs.3,4

The Terms describe automatic charges at the intervals shown for the product. An introductory price does not establish a permanent rate, and paying quarterly can leave unused supply or care time if your needs change. Ask whether cancellation stops a later renewal, a not-yet-submitted prescription or an already-paid quarter, and whether any amount remains payable.

The refund page says prescription returns are not accepted and sales are final. It separately addresses an insurance-backed GLP-1 subscription: lack of candidacy or approval cancels the subscription, but fees already paid are nonrefundable. That limited section should not be presented as a guaranteed refund—or automatically transferred to every compounded cash-pay arrangement.5

Diagnostic lab purchases and lab subscriptions are also described as final and nonrefundable. Optional labs therefore represent a separate buying decision, not a free benefit established by the medication headline. Confirm whether any selected laboratory or other service adds to the initial charge.5

Cancellation and pharmacy boundaries

ItemPublished terms
Product-page wordingAdjust or cancel anytime
General subscription termsThree-month minimum; 30-day processing notice
Insurance-backed nonapprovalSubscription canceled; paid fees nonrefundable
DispensingNamed network; individual pharmacy must be confirmed
Cancellation and pharmacy boundaries

Compounded preparation and named pharmacy network

The offer is compounded tirzepatide. The page says compounded medicines are not FDA-approved and have not been evaluated by FDA for safety, quality or effectiveness. Brand-drug trials and a familiar ingredient name do not establish equivalent results or approval for the specific dispensed preparation. See whether compounded tirzepatide is still legal in 2026 for that separate context.

The Terms name multiple pharmacy partners, including Strive, Pharmacy Hub, Tailor Made, Cadre Labs, Empower, GiftHealth and Partell. A network disclosure is useful, but it does not identify the pharmacy filling a particular tirzepatide order, verify its license independently or establish one regulatory classification for the entire network. Confirm the actual dispenser and ingredients when a prescription is issued.4

FDA issued Joi + Blokes a warning letter on June 8, 2026 about misleading compounded-drug claims and labeling that suggested the platform compounded the products. Compounded products are not FDA-approved. The current product page does not establish that FDA has resolved the concerns in that letter.6

Evaluate care and outcomes separately

The site displays customer ratings and testimonials. This review does not independently audit those reviews, validate a satisfaction ranking or use them to forecast weight loss. Check the actual care and product disclosures rather than choosing on a review-count headline. Discuss Zepbound side effects, the gallbladder risk, and the thyroid cancer warning with your clinician.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

Comparing a complete quarterly offer

The practical decision is whether the selected quarterly charge, coaching support and cancellation rules fit your circumstances. Elara Health and Wellness, DrBrainRx and Luvo Health describe different arrangements, not endorsements or equivalent contracts. Use the provider comparison to compare the actual supply, amount due and next processing date.

Frequently asked questions

Is tirzepatide $99 or $149 for the first month?

The named tirzepatide card says $149; $99 belongs to semaglutide. Ongoing tirzepatide is labeled $249/month billed quarterly.3

Are labs required?

The current product page says labs are optional, while lab sales have separate nonrefund terms.3,5

Can I cancel without a commitment?

The page says cancel anytime, but the Terms describe a three-month minimum and 30-day processing notice after that commitment. Confirm the specific plan’s rule.3,4

Does medical nonapproval guarantee a refund?

No. The insurance-backed policy says the subscription is canceled if not approved but paid subscription fees are nonrefundable. Do not transfer that scoped policy to every cash-pay offer.5

References(6)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. Joi + Blokes (2026). Current compounded GLP-1/GIP product and quarterly pricing. Joi + Blokes.
  4. Joi + Blokes (2025). Terms of Use, updated September 15, 2025. Joi + Blokes.
  5. Joi + Blokes (2026). Refund and Return Policy. Joi + Blokes.
  6. U.S. Food and Drug Administration (2026). Joi and Blokes dba Joi + Blokes, Warning Letter MARCS-CMS 728283, June 8, 2026. FDA. Read source

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.